Colorimetric and thin-layer chromatographic methods for field assay of chloroquine and its metabolites in urine.
Three field-adapted methods for the quantification of the antimalarial drug chloroquine are described. Two of the methods are modifications of the Haskins test and are based on ion-pair formation between chloroquine and methyl orange in either dichloromethane or chloroform. Absorbance values measured at 420 nm with a hand-held, battery-operated filter photometer were linearly related to chloroquine concentrations in urine up to 100 mumol/l (32 mug/ml) for both methods. The contribution of the desethylchloroquine metabolite to the measured absorbance for both methods is less than that of chloroquine; the relative sensitivity for this metabolite is about 50% of that of chloroquine for both methods. The detection limit for modification I is 1 mumol/l (0.3 mug/ml), while that for modification II is 3 mumol/l (1 mug/ml). A single dose of chloroquine diphosphate (300 mg as base) administered to each of three volunteers yielded detectable levels by modification I of chloroquine in the urine for 28 days after dosing. Results for the colorimetric methods correlated well with the liquid chromatographic reference method used. The related thin-layer chromatographic method confirmed the presence of chloroquine and desethylchloroquine in the urine and permitted independent estimation of the concentration of these two compounds if desired. The two colorimetric methods may be used in remote locations where no electricity is available.
D002738:Chloroquine / Q000031:analogs & derivatives* / Q000652:urine*; D002855:Chromatography, Thin Layer / Q000379:methods*; D003124:Colorimetry / Q000379:methods*; D006801:Humans
D002738:Chloroquine; C007278:desethylchloroquine